For research use only. Not for therapeutic Use.
DSRM-3716(Cat No.:I026569)is a selective inhibitor of the protein kinase CK2 (casein kinase 2), an enzyme that plays a key role in regulating various cellular processes, including cell growth, proliferation, and apoptosis. CK2 is often overactive in cancer cells and contributes to tumorigenesis and resistance to chemotherapy. By inhibiting CK2, DSRM-3716 aims to disrupt these oncogenic pathways and reduce cancer cell survival, making it a potential therapeutic candidate for cancer treatment. Preclinical studies suggest that DSRM-3716 may be effective against various cancers, including solid tumors and hematological malignancies, but further clinical evaluation is needed.
Catalog Number | I026569 |
CAS Number | 58142-99-7 |
Synonyms | DSRM-3716; DSRM3716; DSRM 3716; |
Molecular Formula | C9H6IN |
Purity | 98% |
Solubility | To be determined |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 5-iodoisoquinoline |
InChI | InChI=1S/C9H6IN/c10-9-3-1-2-7-6-11-5-4-8(7)9/h1-6H |
InChIKey | CUILFTFMBBGSFT-UHFFFAOYSA-N |
SMILES | C1=CC2=C(C=CN=C2)C(=C1)I |